Cancer                                
                                                            ROCHESTER, Minn. — A genomic test co-developed by Mayo Clinic and SkylineDx can identify whether people with melanoma are at low or high risk for[...]
Latest stories
                            
                            
                            
                            
                                    Research                                
                                                            August 29, 2020
                                
                                    Research                                
                                                            August 28, 2020
                                
                            
                                    Clinical Trials                                
                                                            August 25, 2020
                                
                            
                                    Cardiovascular                                
                                                            August 24, 2020
                                Sign up to receive email notifications
Explore more topics
 Sign up
              
                              Mayo Clinic Connect
An online patient support community